The severity of menstrual dysfunction as a predictor of insulin resistance in pcos

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 12, 2013, Pages

  Brower, Meredith ^a   Brennan, Kathleen ^a   Pall, Marita ^b   Azziz, Ricardo ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; AGE; ANAMNESIS; ANDROGEN BLOOD LEVEL; ANOVULATION; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION DISORDER; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; OVULATION; PHYSICAL EXAMINATION; POLYMENORRHEA; PRASTERONE SULFATE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; RACE; TERTIARY HEALTH CARE; TESTOSTERONE BLOOD LEVEL; VAGINA BLEEDING;

ADULT; ANOVULATION; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MENSTRUATION DISTURBANCES; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84889799237     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2815     Document Type: Article

References (19)

1. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: the complete task force report. Fertil Steril. 2009;91:456-488
2. Salley KE, Wickham EP, Cheang KI, Essah PA, KarjaneNW,Nestler JE. Glucose intolerance in polycystic ovary syndrome - a position statement of the Androgen Excess Society. J Clin Endocrinol Metab. 2007;92:4546-4556
3. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95:2038-2049
4. Roumain J, Charles MA, De Courten MP, et al. The relationship of menstrual irregularity to type 2 diabetes in Pima Indian women. Diabetes Care. 1998;21:346-349
5. Solomon CG, Hu FB, Dunaif A, et al. Long or highly irregular menstrual cycles as a marker for type 2 diabetes mellitus. JAMA. 2001; 286:2421-2426
6. Azziz R, Waggoner WT, Ochoa T, Knochenhauer ES, Boots LR. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril. 1998;70:274-278
7. Carmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol. 1998;139:421-423
8. Rotterdam ESHRE/ASRM sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovarian syndrome. Fertil Steril. 2004;81:19-25
9. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967; 12:77-126
10. Chiazze L Jr, Brayer FT, Macisco JJ Jr, Parker MP, Duffy BJ. The length and variability of the human menstrual cycle. JAMA. 1968; 203:377-380
11. Wathen NC, Perry L, Lilford RJ, Chard T. Interpretation of single progesterone measurements in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J. 1984;288:7-9
12. Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update. 2010;1:51-64
13. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Bots LR, Azziz R. Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078-3082
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologica. 2000;43:1507-1511
15. Bonora E, Targher G, Alberichie M, Bonadonna RC, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care. 2000;23:57- 63
16. Strowitzki T, Capp E, von Eye Corleta H. The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients. Eur J Obstet Gynecol Reprod Biol. 2010; 149:178-181
17. Ezeh U, Yildiz BO, Azziz R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98:1088-1096
18. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87: 1017-1023
19. Vrbíková J, Fanta M, Pelikánová T, Skrha J, Marek J; Czech Endocrine and Czech Diabetological Societies, Androgen Excess Society. [A recommended approach to evaluate cardiovascular risk and to prevent cardiovascular diseases and type 2 diabetes mellitus in women with polycystic ovary syndrome]. Vnitr Lek. 2012;58:56 -57